Nader Pourhassan says his main goal is saving people's lives. From now to next interim leronlimab might save 30-40 lives. Submitting data to the FDA now could possibly save 70,000 - 80,000 in that same time frame on approval. No there doesn't have to be a halt to the trial and any negative consequences to the ongoing trial would be small. If he really wants to save lives he should do the right thing.